New laser-and-cream combo could replace the knife for skin cancer
NCT ID NCT07010692
First seen Nov 01, 2025 · Last updated Jun 15, 2026 · Updated 36 times
Summary
This study tests whether using special lasers followed by a skin ointment (tirbanibulin) can effectively treat two common types of skin cancer: basal cell and squamous cell carcinoma. About 100 adults with biopsy-confirmed skin cancers will receive the laser treatment and then apply the ointment for five nights. The goal is to clear the cancer without surgery, leaving a better cosmetic result and offering a simpler option for many patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SQUAMOUS CELL CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Bruce Robinson, MD
RECRUITINGNew York, New York, 10022, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.